Literature DB >> 3860835

Production and characterization of a monoclonal antibody to a human interferon-induced double-stranded RNA-binding Mr 68,000 protein kinase.

L J Penn, B R Williams.   

Abstract

One of the interferon-induced proteins thought to be involved in the antiviral effects of interferon is a double-stranded RNA-dependent protein kinase. This paper reports the development of a monoclonal antibody, 10A5, that recognizes a protein that co-migrates with the double-stranded RNA-dependent protein kinase at an approximate molecular weight of 68,000. Levels of this protein and of the protein kinase activity increase 3-fold on interferon treatment of T98G cells. The specificity of the monoclonal antibody was determined by ELISA, immunoblotting, and immunoprecipitation procedures. Furthermore, immunoaffinity chromatography of an interferon-induced T98G cell extract previously phosphorylated in the presence of double-stranded RNA and radiolabeled ATP resulted in the specific elution of a phosphorylated Mr 68,000 protein from the monoclonal antibody 10A5-Sepharose column. Monoclonal antibody 10A5 recognizes both native and denatured protein kinase, independent of double-stranded RNA binding or phosphorylation, and should therefore serve as a useful tool in analyzing the role of the double-stranded RNA-dependent protein kinase in the mechanism of interferon action.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3860835      PMCID: PMC390477          DOI: 10.1073/pnas.82.15.4959

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  T98G: an anchorage-independent human tumor cell line that exhibits stationary phase G1 arrest in vitro.

Authors:  G H Stein
Journal:  J Cell Physiol       Date:  1979-04       Impact factor: 6.384

2.  2'5'Oligo(A) polymerase activity and inhibition of viral RNA synthesis in interferon-treated HeLa cells.

Authors:  C Baglioni; P A Maroney; D K West
Journal:  Biochemistry       Date:  1979-05-01       Impact factor: 3.162

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Interferon-induced proteins in human fibroblasts and development of the antiviral state.

Authors:  B Y Rubin; S L Gupta
Journal:  J Virol       Date:  1980-05       Impact factor: 5.103

6.  Antiviral response and induction of specific proteins in cells treated with immune T (type II) interferon analogous to that from viral interferon (type I)-treated cells.

Authors:  A G Hovanessian; E Meurs; O Aujean; C Vaquero; S Stefanos; E Falcoff
Journal:  Virology       Date:  1980-07-15       Impact factor: 3.616

7.  Fibroblast interferon induces synthesis of four proteins in human fibroblast cells.

Authors:  E Knight; B D Korant
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

8.  Characterisation of the interferon-mediated protein kinase by polyclonal antibodies.

Authors:  A G Laurent; B Krust; J Svab; A G Hovanessian
Journal:  Biochem Biophys Res Commun       Date:  1984-11-30       Impact factor: 3.575

Review 9.  Production of monoclonal antibodies: strategy and tactics.

Authors:  S F de StGroth; D Scheidegger
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

10.  Interferon action: induction of specific proteins in mouse and human cells by homologous interferons.

Authors:  S L Gupta; B Y Rubin; S L Holmes
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

View more
  1 in total

1.  Production of a monoclonal antibody directed against an interferon-induced 56,000-dalton protein and its use in the study of this protein.

Authors:  B Y Rubin; S L Anderson; R M Lunn; G R Hellermann; N K Richardson; L J Smith
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.